Hunter C Smith insider trades

Open-market stock purchases and sales by Hunter C Smith, Chief Financial Officer at Rhythm Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 31, 2015.

Recent trades

DateStockTradeValue
Aug 31, 2026RYTM Rhythm Pharmaceuticals, IncSold$2.4M
Aug 31, 2026RYTM Rhythm Pharmaceuticals, IncSold$1.2M
Aug 31, 2026RYTM Rhythm Pharmaceuticals, IncSold$3M
Aug 31, 2026RYTM Rhythm Pharmaceuticals, IncBought (not open market)—
May 18, 2026RYTM Rhythm Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026RYTM Rhythm Pharmaceuticals, IncBought (not open market)—
Feb 19, 2026RYTM Rhythm Pharmaceuticals, IncSold$131K
Feb 19, 2026RYTM Rhythm Pharmaceuticals, IncSold$171K
Feb 19, 2026RYTM Rhythm Pharmaceuticals, IncSold$81.7K
Feb 19, 2026RYTM Rhythm Pharmaceuticals, IncSold$60.4K
Feb 17, 2026RYTM Rhythm Pharmaceuticals, IncSold$119K
Feb 17, 2026RYTM Rhythm Pharmaceuticals, IncSold$91.5K
Feb 17, 2026RYTM Rhythm Pharmaceuticals, IncSold$110K
Feb 17, 2026RYTM Rhythm Pharmaceuticals, IncSold$20.8K
Feb 12, 2026RYTM Rhythm Pharmaceuticals, IncSold$28.1K
Feb 12, 2026RYTM Rhythm Pharmaceuticals, IncSold$39.1K
Feb 12, 2026RYTM Rhythm Pharmaceuticals, IncSold$79.2K
Feb 12, 2026RYTM Rhythm Pharmaceuticals, IncSold$10K
Feb 11, 2026RYTM Rhythm Pharmaceuticals, IncSold$223K
Feb 11, 2026RYTM Rhythm Pharmaceuticals, IncSold$39.8K
Feb 11, 2026RYTM Rhythm Pharmaceuticals, IncSold$10.1K
Feb 11, 2026RYTM Rhythm Pharmaceuticals, IncBought (not open market)—
Feb 11, 2026RYTM Rhythm Pharmaceuticals, IncBought (not open market)—
Feb 10, 2026RYTM Rhythm Pharmaceuticals, IncSold$196K
Feb 10, 2026RYTM Rhythm Pharmaceuticals, IncSold$72.6K

Companies traded

  • RYTM Rhythm Pharmaceuticals, Inc: 51 sales, last Aug 31, 2026
  • AGLE Aeglea BioTherapeutics, Inc: other filings, last Jun 22, 2023
  • GWR Genesee & Wyoming Inc: other filings, last Dec 30, 2019

Get free alerts when Hunter C Smith files a new trade →